SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-064786
Filing Date
2022-05-25
Accepted
2022-05-25 19:00:27
Documents
2
Period of Report
2022-05-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2216827-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2216827-1_4seq1.xml 4 4073
2 EXHIBIT 24 tm2216827d1_ex24.htm EX-24 8839
  Complete submission text file 0001104659-22-064786.txt   14481
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8601 SIX FORKS ROAD SUITE 160 RALEIGH NC 27615
Business Address
Drutz David (Reporting) CIK: 0001428764 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 22964517